132 related articles for article (PubMed ID: 29289448)
1. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
[TBL] [Abstract][Full Text] [Related]
2. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.
Bibian M; Rahaim RJ; Choi JY; Noguchi Y; Schürer S; Chen W; Nakanishi S; Licht K; Rosenberg LH; Li L; Feng Y; Cameron MD; Duckett DR; Cleveland JL; Roush WR
Bioorg Med Chem Lett; 2013 Aug; 23(15):4374-80. PubMed ID: 23787102
[TBL] [Abstract][Full Text] [Related]
3. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
[TBL] [Abstract][Full Text] [Related]
4. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of αENaC expression and ENaC activity following blockade of the circadian clock-regulatory kinases CK1δ/ε.
Richards J; Greenlee MM; Jeffers LA; Cheng KY; Guo L; Eaton DC; Gumz ML
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F918-27. PubMed ID: 22832921
[TBL] [Abstract][Full Text] [Related]
8. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Janovska P; Verner J; Kohoutek J; Bryjova L; Gregorova M; Dzimkova M; Skabrahova H; Radaszkiewicz T; Ovesna P; Vondalova Blanarova O; Nemcova T; Hoferova Z; Vasickova K; Smyckova L; Egle A; Pavlova S; Poppova L; Plevova K; Pospisilova S; Bryja V
Blood; 2018 Mar; 131(11):1206-1218. PubMed ID: 29317454
[TBL] [Abstract][Full Text] [Related]
9. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.
Long AM; Zhao H; Huang X
J Med Chem; 2012 Nov; 55(22):10307-11. PubMed ID: 23106386
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.
Long A; Zhao H; Huang X
J Med Chem; 2012 Jan; 55(2):956-60. PubMed ID: 22168824
[TBL] [Abstract][Full Text] [Related]
12. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
[TBL] [Abstract][Full Text] [Related]
13. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
[TBL] [Abstract][Full Text] [Related]
14. The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/epsilon.
Sugiyama Y; Hatano N; Sueyoshi N; Suetake I; Tajima S; Kinoshita E; Kinoshita-Kikuta E; Koike T; Kameshita I
Biochem J; 2010 Apr; 427(3):489-97. PubMed ID: 20192920
[TBL] [Abstract][Full Text] [Related]
15. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
[TBL] [Abstract][Full Text] [Related]
16. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model.
Adler P; Mayne J; Walker K; Ning Z; Figeys D
J Proteome Res; 2019 Sep; 18(9):3383-3393. PubMed ID: 31334659
[TBL] [Abstract][Full Text] [Related]
18. Ligand-protein interactions of selective casein kinase 1δ inhibitors.
Mente S; Arnold E; Butler T; Chakrapani S; Chandrasekaran R; Cherry K; DiRico K; Doran A; Fisher K; Galatsis P; Green M; Hayward M; Humphrey J; Knafels J; Li J; Liu S; Marconi M; McDonald S; Ohren J; Paradis V; Sneed B; Walton K; Wager T
J Med Chem; 2013 Sep; 56(17):6819-28. PubMed ID: 23919824
[TBL] [Abstract][Full Text] [Related]
19. Effects of a selective casein kinase 1δ and ε inhibitor on FcεRI expression and IgE-mediated immediate-type cutaneous reactions in dogs.
Ohno H; Takahashi K; Yanuma N; Ogawa M; Hasegawa A; Sugita K; Kawano K; Sasaki K; Shirai J; Nagaoka K; Ohmori K
J Vet Med Sci; 2019 Dec; 81(11):1680-1684. PubMed ID: 31582600
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε.
Yang Y; Xu T; Zhang Y; Qin X
Cell Signal; 2017 Feb; 31():58-65. PubMed ID: 28057520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
